Modern Oral drove strong top-line growth, now comprising nearly half of total revenue, with significant gains in retail distribution and brand investment. EBITDA declined due to increased marketing spend, but full-year sales guidance was raised for Modern Oral, reflecting continued momentum.Based o…
Modern Oral drove 23% sales growth and now accounts for nearly half of total revenue, with strong retail expansion and brand investments. EBITDA declined due to higher marketing spend, but full-year sales guidance was raised for Modern Oral, reflecting confidence in continued momentum.Based on Turn…
The Board of Directors of Turning Point Brands, Inc. (“TPB”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products including alternative smoking accessories and consumables with active ingredients, declared a regular quarterly dividend of $0.08 per common share. The div…
